Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE:002020)

Market Cap	16.68B
Revenue (ttm)	4.00B
Net Income (ttm)	712.56M
Shares Out	813.76M
EPS (ttm)	0.86
PE Ratio	23.90
Forward PE	21.28
Dividend	0.35 (1.71%)
Ex-Dividend Date	May 29, 2025

Volume	16,420,595
Average Volume	14,870,357
Open	18.58
Previous Close	20.87
Day's Range	18.58 - 21.58
52-Week Range	11.70 - 22.62
Beta	-0.05
RSI	62.29
Earnings Date	Mar 30, 2026

About SHE:002020

Zhejiang Jingxin Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products and medical devices in China and internationally. The company offers antihypertensive, antibiotics, quinolones, gastrointestinal promotion, antidiabetic, antiepileptic, antihistamine, H+ pump depressant, antihyper cholesterolemia, histamine H2 receptor blockader, antihyper cholesterolemirs, antidepressant, cephalosporin, and biopharma products; and API products, including ciprofloxacin, ciprofloxacin hydrochloride, ciprofloxacin lactat...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 3,869
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002020

Financial Performance

In 2024, SHE:002020's revenue was 4.16 billion, an increase of 3.99% compared to the previous year's 4.00 billion. Earnings were 711.96 million, an increase of 15.04%.